Analystreport

Atara Biotherapeutics (NASDAQ:ATRA) was downgraded by analysts at Weiss Ratings from a "hold (c-)" rating to a "sell (d+)" rating.

Atara Biotherapeutics, Inc.  (ATRA) 
Last atara biotherapeutics, inc. earnings: 2/27 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.atarabio.com/investor-relations